| | Class 2 Device Recall Fungitell Assay |  |
| Date Initiated by Firm | December 19, 2018 |
| Create Date | May 14, 2019 |
| Recall Status1 |
Terminated 3 on May 12, 2020 |
| Recall Number | Z-1329-2019 |
| Recall Event ID |
82551 |
| Product Classification |
Antigen, invasive fungal pathogens - Product Code NQZ
|
| Product | Fungitell Kit, Catalog FT001 - Product Usage: The Fungitell assay is a potease zymogen-based colorimetric assay for the qualitative detection of (1-3)Beta-D Glucan in the serum of patients with symptoms of,or medical conditions predisposing the patient to, invasive fungal infection. The serum concentration of (1-3)Beta-D Glucan, a major cell wall component of various medically important fungi, can be used as an aid in teh diagnosis of deep-seated mycoses and funemias. A positve result does not indicate which genus of fungi may be causing the infection. (1-3)Beta-D Glucan titers should be used in conjunction with other diagnostic procedures, such as microbiological culture, histological examination of biopsy samples and radiological examination. |
| Code Information |
Lot FK18005 |
| FEI Number |
1219145
|
Recalling Firm/ Manufacturer |
Associates of Cape Cod, Inc. 124 Bernard E Saint Jean East Falmouth MA 02536-4445
|
| For Additional Information Contact | 508-540-3444 |
Manufacturer Reason for Recall | The kits may contain the incorrect number of components or the kits may be missing components. |
FDA Determined Cause 2 | Mixed-up of materials/components |
| Action | Important Message to Customers Concerning Fungitell Kit Configuration letters dated 12/19/18 were sent to customers. |
| Quantity in Commerce | 795 |
| Distribution | Worldwide distribution - US nationwide in the states of CA, FL, MD, UT, VA and countries of Singapore, South Africa, United Kingdo.m |
| Total Product Life Cycle | TPLC Device Report |
|
1 A record in this database is created when a firm initiates a correction or removal action. The record is updated if the FDA identifies a violation and classifies the action as a recall, and it is updated for a final time when the recall is terminated. Learn more about medical device recalls. 2 Per FDA policy, recall cause determinations are subject to modification up to the point of termination of the recall. 3 For details about termination of a recall see Code of Federal Regulations (CFR) Title 21 §7.55.
|
|
|
|